Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G
- 2 May 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (12) , 3180-3183
- https://doi.org/10.1016/j.bmcl.2006.03.042
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Asymmetric Total Syntheses of (−)-Jorumycin, (−)-Renieramycin G, 3-epi-Jorumycin, and 3-epi-Renieramycin GJournal of the American Chemical Society, 2005
- Total Synthesis of Cribrostatin IV: Fine-Tuning the Character of an Amide Bond by Remote ControlJournal of the American Chemical Society, 2005
- Chemistry of renieramycins. Part 6: Transformation of renieramycin M into jorumycin and renieramycin J including oxidative degradation products, mimosamycin, renierone, and renierol acetateTetrahedron, 2004
- Novel design of a pentacyclic scaffold as structural mimic of saframycin ATetrahedron, 2003
- A Solid-Supported, Enantioselective Synthesis Suitable for the Rapid Preparation of Large Numbers of Diverse Structural Analogues of (−)-Saframycin AJournal of the American Chemical Society, 2002
- Ecteinascidin 743: a novel anticancer drug with a unique mechanism of actionAnti-Cancer Drugs, 2002
- A New Antitumor Isoquinoline Alkaloid from the Marine Nudibranch Jorunna funebrisTetrahedron, 2000
- Renieramycin G, a new alkaloid from the sponge Xestospongia caycedoiTetrahedron Letters, 1992
- Computer simulation of the binding of saframycin A to d(GATGCATC)2Journal of Medicinal Chemistry, 1991